EcoR1 Capital, LLC
- SEC CIK
- 0001587114
- 最新申報
- 2026/8/14
2021 年第 3 季持倉
持倉截至 2021/9/30，2021/11/22 申報。只含多頭部位，變化是跟 2021 年第 2 季比股數。
- 持股檔數
- 69
- 較 2021 年第 2 季 −3
- 總值
- $28.3 億
- 較 2021 年第 2 季 +$1.66 億 (+6.2%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| PRTAProthena Corp Public Ltd Co | SHS | 11,284,280 | $8.04 億 | 28.4% | 00.0% | 不變 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 3,951,566 | $2.24 億 | 7.9% | 00.0% | 不變 | 歷史 |
| ANABAnaptysbio, Inc | COM | 7,521,024 | $2.04 億 | 7.2% | 00.0% | 不變 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 5,122,359 | $1.79 億 | 6.3% | +1,787,112+53.6% | 加碼 | 歷史 |
| XNCRXencor Inc | COM | 4,906,106 | $1.60 億 | 5.7% | 00.0% | 不變 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 13,711,517 | $1.36 億 | 4.8% | 00.0% | 不變 | 歷史 |
| ALECAlector, Inc. | COM | 4,994,970 | $1.14 億 | 4.0% | +752,336+17.7% | 加碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 464,298 | $8,214 萬 | 2.9% | 00.0% | 不變 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 1,558,749 | $8,201 萬 | 2.9% | +1,558,749 | 新進 | 歷史 |
| STTKShattuck Labs, Inc. | COM | 3,709,072 | $7,559 萬 | 2.7% | +390,662+11.8% | 加碼 | 歷史 |
| ORICOric Pharmaceuticals, Inc. | COM | 3,468,944 | $7,254 萬 | 2.6% | +376,726+12.2% | 加碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 3,724,437 | $6,976 萬 | 2.5% | 00.0% | 不變 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 2,759,505 | $6,797 萬 | 2.4% | +655,555+31.2% | 加碼 | – |
| GRTSGritstone bio, Inc. | COM | 5,560,748 | $6,006 萬 | 2.1% | +2,139,461+62.5% | 加碼 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 1,385,276 | $4,368 萬 | 1.5% | −3,102,500−69.1% | 減碼 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 1,303,157 | $3,519 萬 | 1.2% | +267,293+25.8% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 1,126,640 | $3,375 萬 | 1.2% | −841,310−42.8% | 減碼 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 1,411,975 | $3,054 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 1,863,098 | $2,737 萬 | 1.0% | +603,079+47.9% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 1,443,800 | $2,558 萬 | 0.9% | +1,443,800 | 新進 | 歷史 |
| DRNADicerna Pharmaceuticals Inc | COM | 1,249,812 | $2,520 萬 | 0.9% | +1,249,812 | 新進 | 歷史 |
| AKUSAkouos, Inc. | COM | 1,975,984 | $2,294 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 9,202,702 | $2,199 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,279,175 | $2,123 萬 | 0.8% | +55,000+4.5% | 加碼 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 6,082,200 | $2,044 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 1,300,000 | $1,681 萬 | 0.6% | +1,300,000 | 新進 | 歷史 |
| BLUEbluebird bio, Inc. | COM | 802,507 | $1,534 萬 | 0.5% | +802,507 | 新進 | 歷史 |
| ERASErasca, Inc. | COM | 700,000 | $1,485 萬 | 0.5% | +700,000 | 新進 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 754,545 | $1,260 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 1,184,710 | $1,182 萬 | 0.4% | −1,433,326−54.7% | 減碼 | 歷史 |
| ODTOdonate Therapeutics, Inc. | COM | 3,727,261 | $1,085 萬 | 0.4% | +2,896,061+348.4% | 加碼 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 2,081,077 | $1,007 萬 | 0.4% | −1,498,300−41.9% | 減碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 1,140,819 | $991.4 萬 | 0.4% | +1,140,819 | 新進 | 歷史 |
| CCCCC4 Therapeutics, Inc. | COM STK | 200,000 | $893.6 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| KRONKronos Bio, Inc. | COM | 387,357 | $811.9 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| NGNENeurogene Inc. | COM | 860,619 | $622.2 萬 | 0.2% | −1,498,185−63.5% | 減碼 | 歷史 |
| FLACFrazier Lifesciences Acquisition Corp | CL A SHS | 587,615 | $577.0 萬 | 0.2% | +387,120+193.1% | 加碼 | 歷史 |
| ACIUAC Immune SA | SHS | 751,251 | $504.1 萬 | 0.2% | −1,896,912−71.6% | 減碼 | 歷史 |
| KRSAKorsana Biosciences, Inc. | COM | 1,606,276 | $493.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| JYACJiya Acquisition Corp. | COM CL A | 500,000 | $487.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 100,000 | $470.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| KNTEKinnate Biopharma Inc. | COM | 175,000 | $402.9 萬 | 0.1% | +150,000+600.0% | 加碼 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $395.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FS Development Corp II30318F100 | COM CL A | 371,014 | $369.2 萬 | 0.1% | +221,014+147.3% | 加碼 | – |
| DYNDyne Therapeutics, Inc. | COM | 215,000 | $356.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| IGMSIGM Biosciences, Inc. | COM | 38,030 | $250.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 90,141 | $209.0 萬 | 0.1% | −15,497−14.7% | 減碼 | 歷史 |
| BCLS Acquisition CorpG0904B105 | COM CL A | 200,000 | $199.2 萬 | 0.1% | 00.0% | 不變 | – |
| MLTXMoonLake Immunotherapeutics | COM CL A | 200,000 | $199.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| 5 01 Acquisition Corp33836P105 | COM CL A | 200,000 | $196.4 萬 | 0.1% | 00.0% | 不變 | – |
| Eucrates Biomedical Acqu CorG3141W106 | SHS | 200,000 | $195.6 萬 | 0.1% | 00.0% | 不變 | – |
| BOLTBolt Biotherapeutics, Inc. | COM | 150,000 | $184.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CRBUCaribou Biosciences, Inc. | COM | 75,000 | $179.0 萬 | 0.1% | +75,000 | 新進 | 歷史 |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 150,000 | $150.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| PMVPPMV Pharmaceuticals, Inc. | COM | 50,000 | $149.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BCABBioAtla, Inc. | COM | 50,000 | $147.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 50,000 | $128.6 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| MGTXMeiraGTx Holdings plc | COM | 94,819 | $125.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| VYGRVoyager Therapeutics, Inc. | COM | 445,992 | $117.3 萬 | <0.1% | +445,992 | 新進 | 歷史 |
| Turmeric Acquisition CorpG9127T108 | CL A | 100,000 | $97.9 萬 | <0.1% | 00.0% | 不變 | – |
| Omega Alpha SpacG6749V107 | CL A | 50,000 | $48.7 萬 | <0.1% | 00.0% | 不變 | – |
| SRRKScholar Rock Holding Corp | COM | 8,208 | $27.1 萬 | <0.1% | +8,208 | 新進 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 7,001 | $7.50 萬 | <0.1% | −515,634−98.7% | 減碼 | 歷史 |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 963,333 | – | – | 00.0% | 不變 | – |
| Eucrates Biomedical Acqu CorG3141W122 | *W EXP 10/23/202 | 66,666 | – | – | 00.0% | 不變 | – |
| Frazier Lifesciences Acqu CoG3710A113 | *W EXP 11/30/202 | 66,665 | – | – | 00.0% | 不變 | – |
| Turmeric Acquisition CorpG9127T124 | *W EXP 10/08/202 | 33,333 | – | – | 00.0% | 不變 | – |
| CareMax, Inc.14171W111 | *W EXP 06/08/202 | 100,000 | – | – | 00.0% | 不變 | – |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 66,665 | – | – | +66,665 | 新進 | – |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2021 年第 2 季之後清倉（14 檔）
2021 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 2 季股數 | 2021 年第 2 季市值 | 2021 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| Translate Bio, Inc.89374L104 | COM | 1,048,976 | $2,889 萬 | 1.1% | – |
| KYMRKymera Therapeutics, Inc. | COM | 519,416 | $2,519 萬 | 0.9% | 歷史 |
| ARVNArvinas, Inc. | COM | 321,724 | $2,477 萬 | 0.9% | 歷史 |
| BCELAtreca, Inc. | CL A COM | 2,426,685 | $2,068 萬 | 0.8% | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 931,650 | $1,316 萬 | 0.5% | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 200,000 | $1,064 萬 | 0.4% | 歷史 |
| BCTG Acquisition Corp05492W103 | COM | 800,000 | $910.4 萬 | 0.3% | – |
| KLRSKalaris Therapeutics, Inc. | COM | 447,012 | $882.4 萬 | 0.3% | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM | 1,000,000 | $545.0 萬 | 0.2% | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 366,867 | $358.8 萬 | 0.1% | 歷史 |
| NGMNGM Biopharmaceuticals Inc | COM | 143,567 | $283.1 萬 | 0.1% | 歷史 |
| Consonance HFW Acquisition CG2445M103 | SHS CL A | 200,000 | $198.7 萬 | 0.1% | – |
| FSTXF-star Therapeutics, Inc. | COM | 46,000 | $39.5 萬 | <0.1% | 歷史 |
| Consonance HFW Acquisition CG2445M111 | *W EXP 10/28/202 | 66,665 | – | – | – |